失眠治疗市场：依治疗方法、通路和地区划分

2026年失眠治疗市场规模估计为44亿美元，预计2033年将达到59.3亿美元。预计2026年至2033年，该市场将以4.3%的复合年增长率成长。

失眠是一种以睡眠问题为特征的睡眠障碍。征兆症状包括入睡困难、难以维持睡眠、感觉休息不足。虽然可以使用安眠药，但了解其副作用至关重要。服用小剂量的处方抗忧郁药物也可能有助于缓解忧郁症。认知行为疗法（CBT-I）通常被推荐为失眠的第一线治疗方法。 CBT-I 是一种系统性的疗法，旨在帮助患者识别导致或加剧睡眠问题的想法和行为，并用促进优质睡眠的习惯取而代之。

市场动态

睡眠障碍的高发生率、对安全有效治疗方法日益增长的需求、意识提升以及全球老年人口的快速增长，预计将推动全球失眠治疗市场在预测期内的成长。与年轻人相比，老年人的失眠盛行率更高。与老龄化相关的生理变化、慢性疾病和环境因素都会导致老年人失眠。因此，随着老年人口的增加，全球对安全有效失眠疗法的需求也不断增长。例如，根据世界卫生组织（WHO）的数据，到2030年，全球六分之一的人口将超过60岁，到2050年，全球60岁以上人口将翻倍（达到21亿）。

本报告的主要特点

• 本报告对全球失眠治疗市场进行了详细分析，包括预测期（2026-2033 年）的市场规模和复合年增长率，以 2025 年为基准年。
• 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本节根据以下参数，介绍全球失眠治疗市场的主要企业概况：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球失眠治疗市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球失眠治疗市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监管与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准
• PEST分析
• 波特五力分析
• 市场机会
• 法规环境
• 主要进展
• 产业趋势

第四章：全球失眠治疗市场：依治疗方法划分（2020-2033 年）

• 製药
• 医疗设备

第五章：全球失眠治疗市场：依通路划分（2020-2033 年）

• 医院药房
• 零售药房
• 其他分销管道

第六章：全球失眠治疗市场：按地区划分（2020-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第七章 竞争情势

• Innovative Neurological Devices
• Cereve Inc.
• Sanofi SA
• Pfizer Inc.
• Paratek Pharmaceuticals Inc.
• Merck &Co. Inc.
• Takeda Pharmaceutical Company Ltd.
• Ebb Therapeutics
• Electromedical Products International Inc.

第八章 分析师建议

• 机会
• 分析师意见
• Coherent Opportunity Map (COM)

第九章 参考文献与分析方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Insomnia Treatment Market is estimated to be valued at USD 4.4 Bn in 2026 and is expected to reach USD 5.93 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2033.

Insomnia, or sleeplessness, is a sleep disorder in which people have trouble sleeping. Signs and symptoms may include difficulty falling or staying asleep and not feeling well-rested. Sleeping pills may also be used, but should be monitored for side effects. Sometimes prescription drugs used to treat depression may ease insomnia when taken in lower doses. Cognitive behavioral therapy for insomnia, CBT-I, is usually recommended as the first line of treatment. CBT-I is a structured program that helps people identify and replace thoughts and behaviors that cause or worsen sleep problems with habits that promote sound sleep.

Market Dynamics

High prevalence of sleep disorders, growing demand for safe and effective treatment, increase in awareness among people, and rapidly growing geriatric population worldwide is expected to augment the growth of the global insomnia treatment market during the forecast period. The prevalence of insomnia is higher in elderly than in the younger population. Physiologic changes of aging, chronic medical illnesses, and environmental conditions contribute to insomnia in the elderly. Thus, with the growing geriatric population, the demand for safe & effective insomnia treatment worldwide. For instance, according to the World Health Organization (WHO), one in six people in the world will be aged 60 years or over by 2030, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key features of the study

• This report provides in-depth analysis of the global insomnia treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global insomnia treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Innovative Neurological Devices, Cereve Inc., Sanofi SA, Pfizer Inc., Paratek Pharmaceuticals Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Ltd., Ebb Therapeutics, and Electromedical Products International Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global insomnia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insomnia treatment market.

Market Segmentation

• Treatment Type Insights (Revenue, USD Bn, 2026 - 2033)
  • Drug
  • Device
• Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • Innovative Neurological Devices
  • Cereve Inc.
  • Sanofi SA
  • Pfizer Inc.
  • Paratek Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Ebb Therapeutics
  • Electromedical Products InternatAional Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Insomnia Treatment Market, By Treatment Type
  • Global Insomnia Treatment Market, By Distribution Channel
  • Global Insomnia Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Insomnia Treatment Market, By Treatment Type, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Drug
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Insomnia Treatment Market, By Distribution Channel, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Other Distribution Channels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Insomnia Treatment Market, By Region, 2020 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Value (USD Bn)
  • Market Size and Forecast, By Treatment Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Innovative Neurological Devices
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cereve Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Paratek Pharmaceuticals Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co. Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takeda Pharmaceutical Company Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ebb Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Electromedical Products International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About us